Skip to content
Wenlo
Sign in
← Markets

Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares

144ROIVFiled Nov 10, 2026, 4:36 PM ET

AI-generated summary

Officer Venker Eric of Roivant Sciences Ltd. proposes to sell 187,943 common shares with an aggregate market value of $7,617,816.56 through Rockefeller Financial LLC. The approximate sale date is November 10, 2026. The sale will be executed pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
Venker Eric
Relationship
Officer
Shares to sell
187,943
Market value
$7,617,816.56
Approximate sale date
Nov 10, 2026
Broker
Rockefeller Financial LLC
Acquired (1)
Mar 20, 2025 · Options Exercise - Grant Date 04/20/2022
Acquired (2)
Feb 13, 2025 · Options Exercise - Grant Date 04/20/2022
Acquired (3)
Mar 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (4)
Feb 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (5)
Jan 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (6)
Nov 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (7)
Oct 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (8)
Mar 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (9)
Jun 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (10)
May 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (11)
Apr 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (12)
Mar 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (13)
Feb 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (14)
Jan 20, 2023 · RSU Grant 018861 - Grant date 05/20/2021

Rule 10b5-1 plan · adopted Jun 30, 2026

Remarks
  1. The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/30/2026.

More ROIV filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.